Drug Development
Research breakthrough: In 2024, we will jointly establish a new drug development research center with the Biological Research Institute of Hunan University, focusing on innovative drugs and high-end generic drugs research and development, and laying out frontier fields such as antibody-drug conjugate (ADC) intermediates.
Intellectual property: More than 50 invention patents have been applied, 25 of which have been authorized, and a number of PCT international patents have been submitted. The technical barriers have been continuously strengthened 10.